• Glioblastoma multiforme studied with analytical chemistry
    Analytical chemistry used to study GBM

Electrophoretic Separations

Glioblastoma multiforme studied with analytical chemistry

Apr 08 2011

Analytical chemistry has been used to study glioblastoma multiforme (GBM).

Published in Proteome Science, the researchers highlight that GBM's genomics, proteomics and transcriptomics could act as biomarkers for therapies, which could include immunotherapy.

Electrophoretic separations and mass spectrometry were used in the study in order to "identify proteins that may serve as brain tumour antigens".

Five samples were compared with Difference In-gel Analysis Software, the researchers explain - and using mass spectrometry 22 proteins were identified.

"Our results confirmed the importance of previously described proteins in glioma pathology and their potential usefulness as biological markers but also revealed some new interesting targets for future therapies," comment the scientists.

Proteome Science is an online journal that publishes papers on proteomics - both structural and functional.

The research released on the site is reviewed by peers prior to being published in an open-access format as soon as possible after approval.

Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions


NGVS 2024

May 23 2024 Beijing, China


May 28 2024 Tel Aviv, Israel


May 28 2024 Leuven, Belgium

PREP 2024

May 28 2024 Philadelphia, PA, USA


May 29 2024 Beijing, China

View all events